This College Choice Could Make You $3Million Richer
The differences in starting salaries for STEM majors versus those who study the humanities have been widely publicized. Now, a new study looks at how those differences add up over a lifetime of earnings – and the results are staggering.
The lowest paid graduates, early childhood education majors, earn just $39,000 annually mid-career, while the highest paid petroleum engineering majors, make an average of $136,000 per year. Over a career, that difference amounts to more than $3 million, according to the report The Economic Value of College Majors by economists at Georgetown University.
Among the major fields of study, architecture and engineering students earn highest average salary--$83,000 per year, and education majors earn the lowest--$45,000 per year.
Related: 10 Public Universities with the Worst Graduation Rates
The study finds that generally it’s still worth it to go to college. The average bachelor’s degree holder makes $1 million more over a lifetime than a person with just a high school diploma.
A separate report released last fall by the Federal Reserve Bank of New York found that the value of a bachelor’s degree has reached an all-time high of around $300,000. Researchers found that it takes about 10 years to recoup the cost of a degree, a historically low level, down from close to 25 years in the late 1970s and 1980s.
So those education majors should still go to college, but they might be smart to look for more moderately priced options and to be more wary about taking on debt than their engineering peers.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
